Nitrofurantoin

Nitrofurantoin

SCHEMBL9813751

O=C1CN(/N=C/c2ccc([N+](=O)[O-])o2)C(=O)N1.[Na+]

nearest known ligand 0.97

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Nitrofurantoin. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA1 known ✓ P30542 1/20 0.66
▸ LMNA P02545 7/20 0.97
▸ MAPT P10636 7/20 0.97
▸ TP53 P04637 5/20 0.97
▸ TDP1 Q9NUW8 4/20 0.97
▸ SMN1; SMN2 Q16637 4/20 0.97
▸ MDM2 Q00987 4/20 0.97
▸ CYP1A2 P05177 3/20 0.97
▸ CYP3A4 P08684 2/20 0.97
▸ CISD1 Q9NZ45 2/20 0.97
▸ KDM4E B2RXH2 2/20 0.97
▸ ABCC4 O15439 1/20 0.97
▸ TSHR P16473 1/20 0.97
▸ MAOA P21397 1/20 0.97
▸ CASP7 P55210 1/20 0.97
▸ HSD17B10 Q99714 1/20 0.97
▸ KMT2A Q03164 3/20 0.66
▸ MEN1 O00255 2/20 0.66
▸ ABCB11 O95342 1/20 0.66
▸ ALDH1A1 P00352 6/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Nitrofurantoin SCHEMBL29472 0.99 LMNA (1.00) LMNAMAPTTP53TDP1SMN1; SMN2
Nitrofurantoin SCHEMBL29470 0.99 LMNA (1.00) LMNAMAPTTP53TDP1SMN1; SMN2
Nitrofurantoin SCHEMBL2508426 0.99 LMNA (1.00) LMNAMAPTTP53TDP1SMN1; SMN2
Nitrofurantoin SCHEMBL29471 0.99 LMNA (1.00) LMNAMAPTTP53TDP1SMN1; SMN2
Nitrofurantoin SCHEMBL668258 0.97 LMNA (0.97) LMNAMAPTTP53TDP1SMN1; SMN2
Nitrofurantoin SCHEMBL547326 0.97 LMNA (0.97) LMNAMAPTTP53TDP1SMN1; SMN2
Nitrofurantoin SCHEMBL3339581 0.97 LMNA (0.97) LMNAMAPTTP53TDP1SMN1; SMN2
Nitrofurantoin SCHEMBL3339573 0.97 LMNA (0.97) LMNAMAPTTP53TDP1SMN1; SMN2
Nitrofurantoin SCHEMBL2323793 0.89 LMNA (0.81) LMNAMAPTTP53TDP1SMN1; SMN2
Nitrofurantoin SCHEMBL2323795 0.89 LMNA (0.81) LMNAMAPTTP53TDP1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021156838-A1 TIO2 NANO-PARTICLES IMPREGNATED SURGICAL SILK SUTURE CHANDRASHEKAR VIDYA KODIGE (IN) 2021-08-12 — — WO claimed
US-4024871-A POLYURETHANE ETHICON, INC. (US) 1977-05-24 — — US claimed
WO-2021156838-A1 TIO2 NANO-PARTICLES IMPREGNATED SURGICAL SILK SUTURE CHANDRASHEKAR VIDYA KODIGE (IN) 2021-08-12 — — WO disclosed
US-20150173738-A1 SURGICAL FIXATION DEVICE WITH ANTIBACTERIAL SUBSTANCE ARTHREX, INC. 2015-06-25 — — US disclosed
EP-0250038-B1 SUSTAINED RELEASE CAPSULE Norwich Eaton Pharmaceuticals, Inc. (US) 1991-08-21 — — EP disclosed
EP-0250023-B1 NITROFURANTOIN DOSAGE FORM Norwich Eaton Pharmaceuticals, Inc. (US) 1991-08-14 — — EP disclosed
US-4798725-A POLYVINYLPYRROLIDONE, CARBOXYVINYL POLYMER NORWICH EATON PHARMACEUTICALS, INC. (US) 1989-01-17 — — US disclosed
US-4772473-A RAPID-AND SUSTAINED-RELEASE CAPSULE NORWICH EATON PHARMACEUTICALS, INC. (US) 1988-09-20 — — US disclosed
EP-0250038-A2 Sustained release capsule Norwich Eaton Pharmaceuticals, Inc. (US) 1987-12-23 — — EP disclosed
EP-0250023-A1 Nitrofurantoin dosage form Norwich Eaton Pharmaceuticals, Inc. (US) 1987-12-23 — — EP disclosed
US-4122158-A FOR TREATMENT OF BURNS; BIODEGRADABLE HYDROPHOBIC POLYMER; SUSTAINED RELEASE ALZA CORPORATION (US) 1978-10-24 — — US disclosed
US-4024871-A POLYURETHANE ETHICON, INC. (US) 1977-05-24 — — US disclosed
US-3987797-A ANTIMICROBIAL SUTURES ETHICON, INC. (US) 1976-10-26 — — US disclosed
US-3983209-A HYDROPHOBIC BIOERODIBLE POLYMER, MICROBIOCIDE OR PROTEOLYTIC ENZYME ALZA CORPORATION (US) 1976-09-28 — — US disclosed
Send feedback